Cargando…
Protocol for the surgical and large bore procedures in malignant pleural mesothelioma and radiotherapy trial (SMART Trial): an RCT evaluating whether prophylactic radiotherapy reduces the incidence of procedure tract metastases
INTRODUCTION: Patients with malignant pleural mesothelioma (MPM) may develop painful ‘procedure tract metastasis’ (PTM) at the site of previous pleural interventions. Prophylactic radiotherapy has been used to minimise this complication; however, three small randomised trials have shown conflicting...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289725/ https://www.ncbi.nlm.nih.gov/pubmed/25575875 http://dx.doi.org/10.1136/bmjopen-2014-006673 |
_version_ | 1782352145805213696 |
---|---|
author | Clive, Amelia O Wilson, Paula Taylor, Hazel Morley, Anna J de Winton, Emma Panakis, Niki Rahman, Najib Pepperell, Justin Howell, Timothy Batchelor, Timothy J P Jordan, Nikki Lee, Y C Gary Dobson, Lee Maskell, Nick A |
author_facet | Clive, Amelia O Wilson, Paula Taylor, Hazel Morley, Anna J de Winton, Emma Panakis, Niki Rahman, Najib Pepperell, Justin Howell, Timothy Batchelor, Timothy J P Jordan, Nikki Lee, Y C Gary Dobson, Lee Maskell, Nick A |
author_sort | Clive, Amelia O |
collection | PubMed |
description | INTRODUCTION: Patients with malignant pleural mesothelioma (MPM) may develop painful ‘procedure tract metastasis’ (PTM) at the site of previous pleural interventions. Prophylactic radiotherapy has been used to minimise this complication; however, three small randomised trials have shown conflicting results regarding its effectiveness. The surgical and large bore procedures in malignant pleural mesothelioma and radiotherapy trial (SMART Trial) is a suitably powered, multicentre, randomised controlled trial, designed to evaluate the efficacy of prophylactic radiotherapy within 42 days of pleural instrumentation in preventing the development of PTM in MPM. METHODS AND ANALYSIS: 203 patients with a histocytologically proven diagnosis of MPM, who have undergone a large bore pleural intervention (thoracic surgery, large bore chest drain, indwelling pleural catheter or local anaesthetic thoracoscopy) in the previous 35 days, will be recruited from UK hospitals. Patients will be randomised (1:1) to receive immediate radiotherapy (21 Gy in 3 fractions over 3 working days within 42 days of the pleural intervention) or deferred radiotherapy (21 Gy in 3 fractions over 3 working days given if a PTM develops). Patients will be followed up for 12 months. The primary outcome measure is the rate of PTM until death or 12 months (whichever is sooner), as defined by the presence of a clinically palpable nodule of at least 1 cm diameter felt within 7 cm of the margins of the procedure site as confirmed by two assessors. Secondary outcome measures include chest pain, quality of life, analgaesic requirements, healthcare utilisation and safety (including radiotherapy toxicity). ETHICS AND DISSEMINATION: The trial has received ethical approval from the Southampton B Research Ethics Committee (11/SC/0408). There is a Trial Steering Committee, including independent members and a patient and public representative. The trial results will be published in a peer-reviewed journal and presented at international conferences. TRIAL REGISTRATION NUMBER: ISRCTN72767336. |
format | Online Article Text |
id | pubmed-4289725 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-42897252015-01-16 Protocol for the surgical and large bore procedures in malignant pleural mesothelioma and radiotherapy trial (SMART Trial): an RCT evaluating whether prophylactic radiotherapy reduces the incidence of procedure tract metastases Clive, Amelia O Wilson, Paula Taylor, Hazel Morley, Anna J de Winton, Emma Panakis, Niki Rahman, Najib Pepperell, Justin Howell, Timothy Batchelor, Timothy J P Jordan, Nikki Lee, Y C Gary Dobson, Lee Maskell, Nick A BMJ Open Respiratory Medicine INTRODUCTION: Patients with malignant pleural mesothelioma (MPM) may develop painful ‘procedure tract metastasis’ (PTM) at the site of previous pleural interventions. Prophylactic radiotherapy has been used to minimise this complication; however, three small randomised trials have shown conflicting results regarding its effectiveness. The surgical and large bore procedures in malignant pleural mesothelioma and radiotherapy trial (SMART Trial) is a suitably powered, multicentre, randomised controlled trial, designed to evaluate the efficacy of prophylactic radiotherapy within 42 days of pleural instrumentation in preventing the development of PTM in MPM. METHODS AND ANALYSIS: 203 patients with a histocytologically proven diagnosis of MPM, who have undergone a large bore pleural intervention (thoracic surgery, large bore chest drain, indwelling pleural catheter or local anaesthetic thoracoscopy) in the previous 35 days, will be recruited from UK hospitals. Patients will be randomised (1:1) to receive immediate radiotherapy (21 Gy in 3 fractions over 3 working days within 42 days of the pleural intervention) or deferred radiotherapy (21 Gy in 3 fractions over 3 working days given if a PTM develops). Patients will be followed up for 12 months. The primary outcome measure is the rate of PTM until death or 12 months (whichever is sooner), as defined by the presence of a clinically palpable nodule of at least 1 cm diameter felt within 7 cm of the margins of the procedure site as confirmed by two assessors. Secondary outcome measures include chest pain, quality of life, analgaesic requirements, healthcare utilisation and safety (including radiotherapy toxicity). ETHICS AND DISSEMINATION: The trial has received ethical approval from the Southampton B Research Ethics Committee (11/SC/0408). There is a Trial Steering Committee, including independent members and a patient and public representative. The trial results will be published in a peer-reviewed journal and presented at international conferences. TRIAL REGISTRATION NUMBER: ISRCTN72767336. BMJ Publishing Group 2015-01-09 /pmc/articles/PMC4289725/ /pubmed/25575875 http://dx.doi.org/10.1136/bmjopen-2014-006673 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Respiratory Medicine Clive, Amelia O Wilson, Paula Taylor, Hazel Morley, Anna J de Winton, Emma Panakis, Niki Rahman, Najib Pepperell, Justin Howell, Timothy Batchelor, Timothy J P Jordan, Nikki Lee, Y C Gary Dobson, Lee Maskell, Nick A Protocol for the surgical and large bore procedures in malignant pleural mesothelioma and radiotherapy trial (SMART Trial): an RCT evaluating whether prophylactic radiotherapy reduces the incidence of procedure tract metastases |
title | Protocol for the surgical and large bore procedures in malignant pleural mesothelioma and radiotherapy trial (SMART Trial): an RCT evaluating whether prophylactic radiotherapy reduces the incidence of procedure tract metastases |
title_full | Protocol for the surgical and large bore procedures in malignant pleural mesothelioma and radiotherapy trial (SMART Trial): an RCT evaluating whether prophylactic radiotherapy reduces the incidence of procedure tract metastases |
title_fullStr | Protocol for the surgical and large bore procedures in malignant pleural mesothelioma and radiotherapy trial (SMART Trial): an RCT evaluating whether prophylactic radiotherapy reduces the incidence of procedure tract metastases |
title_full_unstemmed | Protocol for the surgical and large bore procedures in malignant pleural mesothelioma and radiotherapy trial (SMART Trial): an RCT evaluating whether prophylactic radiotherapy reduces the incidence of procedure tract metastases |
title_short | Protocol for the surgical and large bore procedures in malignant pleural mesothelioma and radiotherapy trial (SMART Trial): an RCT evaluating whether prophylactic radiotherapy reduces the incidence of procedure tract metastases |
title_sort | protocol for the surgical and large bore procedures in malignant pleural mesothelioma and radiotherapy trial (smart trial): an rct evaluating whether prophylactic radiotherapy reduces the incidence of procedure tract metastases |
topic | Respiratory Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289725/ https://www.ncbi.nlm.nih.gov/pubmed/25575875 http://dx.doi.org/10.1136/bmjopen-2014-006673 |
work_keys_str_mv | AT cliveameliao protocolforthesurgicalandlargeboreproceduresinmalignantpleuralmesotheliomaandradiotherapytrialsmarttrialanrctevaluatingwhetherprophylacticradiotherapyreducestheincidenceofproceduretractmetastases AT wilsonpaula protocolforthesurgicalandlargeboreproceduresinmalignantpleuralmesotheliomaandradiotherapytrialsmarttrialanrctevaluatingwhetherprophylacticradiotherapyreducestheincidenceofproceduretractmetastases AT taylorhazel protocolforthesurgicalandlargeboreproceduresinmalignantpleuralmesotheliomaandradiotherapytrialsmarttrialanrctevaluatingwhetherprophylacticradiotherapyreducestheincidenceofproceduretractmetastases AT morleyannaj protocolforthesurgicalandlargeboreproceduresinmalignantpleuralmesotheliomaandradiotherapytrialsmarttrialanrctevaluatingwhetherprophylacticradiotherapyreducestheincidenceofproceduretractmetastases AT dewintonemma protocolforthesurgicalandlargeboreproceduresinmalignantpleuralmesotheliomaandradiotherapytrialsmarttrialanrctevaluatingwhetherprophylacticradiotherapyreducestheincidenceofproceduretractmetastases AT panakisniki protocolforthesurgicalandlargeboreproceduresinmalignantpleuralmesotheliomaandradiotherapytrialsmarttrialanrctevaluatingwhetherprophylacticradiotherapyreducestheincidenceofproceduretractmetastases AT rahmannajib protocolforthesurgicalandlargeboreproceduresinmalignantpleuralmesotheliomaandradiotherapytrialsmarttrialanrctevaluatingwhetherprophylacticradiotherapyreducestheincidenceofproceduretractmetastases AT pepperelljustin protocolforthesurgicalandlargeboreproceduresinmalignantpleuralmesotheliomaandradiotherapytrialsmarttrialanrctevaluatingwhetherprophylacticradiotherapyreducestheincidenceofproceduretractmetastases AT howelltimothy protocolforthesurgicalandlargeboreproceduresinmalignantpleuralmesotheliomaandradiotherapytrialsmarttrialanrctevaluatingwhetherprophylacticradiotherapyreducestheincidenceofproceduretractmetastases AT batchelortimothyjp protocolforthesurgicalandlargeboreproceduresinmalignantpleuralmesotheliomaandradiotherapytrialsmarttrialanrctevaluatingwhetherprophylacticradiotherapyreducestheincidenceofproceduretractmetastases AT jordannikki protocolforthesurgicalandlargeboreproceduresinmalignantpleuralmesotheliomaandradiotherapytrialsmarttrialanrctevaluatingwhetherprophylacticradiotherapyreducestheincidenceofproceduretractmetastases AT leeycgary protocolforthesurgicalandlargeboreproceduresinmalignantpleuralmesotheliomaandradiotherapytrialsmarttrialanrctevaluatingwhetherprophylacticradiotherapyreducestheincidenceofproceduretractmetastases AT dobsonlee protocolforthesurgicalandlargeboreproceduresinmalignantpleuralmesotheliomaandradiotherapytrialsmarttrialanrctevaluatingwhetherprophylacticradiotherapyreducestheincidenceofproceduretractmetastases AT maskellnicka protocolforthesurgicalandlargeboreproceduresinmalignantpleuralmesotheliomaandradiotherapytrialsmarttrialanrctevaluatingwhetherprophylacticradiotherapyreducestheincidenceofproceduretractmetastases |